C7 peptide can prevent metastasis and invasion in liver cancer by inhibiting the Akt and Erk1/2 signaling pathway, blocking the combination of HGF and c-Met, and inhibiting HGF/c-Met and its downstream signaling pathway (Zhao et al., 2019b). Here, MAPK3 is linked to liver cancer.